↓ Skip to main content

Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry

Overview of attention for article published in Journal of Crohn's and Colitis Supplements, September 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs
1 blog
twitter
50 X users
facebook
1 Facebook page

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
95 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry
Published in
Journal of Crohn's and Colitis Supplements, September 2020
DOI 10.1093/ecco-jcc/jjaa145
Pubmed ID
Authors

María Chaparro, Ana Garre, Francisco Mesonero, Cristina Rodríguez, Manuel Barreiro-de Acosta, Jesús Martínez-Cadilla, María T Arroyo, Noemí Manceñido, Mónica Sierra-Ausín, Isabel Vera-Mendoza, María José Casanova, Pilar Nos, Carlos González-Muñoza, Teresa Martínez, Maia Boscá-Watts, Margalida Calafat, David Busquets, Eva Girona, Jordina Llaó, María Dolores Martín-Arranz, Marta Piqueras, Laura Ramos, Gerard Surís, Fernando Bermejo, Ana Y Carbajo, Diego Casas-Deza, Agnes Fernández-Clotet, María J García, Daniel Ginard, Ana Gutiérrez-Casbas, Luis Hernández, Alfredo J Lucendo, Lucía Márquez, Olga Merino-Ochoa, Francisco J Rancel, Carlos Taxonera, Antonio López Sanromán, Saioa Rubio, Eugeni Domènech, Javier P Gisbert

X Demographics

X Demographics

The data shown below were collected from the profiles of 50 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 95 100%

Demographic breakdown

Readers by professional status Count As %
Other 10 11%
Researcher 9 9%
Unspecified 7 7%
Student > Bachelor 7 7%
Librarian 5 5%
Other 21 22%
Unknown 36 38%
Readers by discipline Count As %
Medicine and Dentistry 29 31%
Pharmacology, Toxicology and Pharmaceutical Science 7 7%
Unspecified 7 7%
Biochemistry, Genetics and Molecular Biology 3 3%
Nursing and Health Professions 3 3%
Other 10 11%
Unknown 36 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 42. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2021.
All research outputs
#1,007,760
of 25,728,855 outputs
Outputs from Journal of Crohn's and Colitis Supplements
#102
of 2,136 outputs
Outputs of similar age
#27,927
of 431,572 outputs
Outputs of similar age from Journal of Crohn's and Colitis Supplements
#5
of 50 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,136 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,572 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.